BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4361896)

  • 1. [Cells of various types activated in vitro by phytohemagglutinin. Target cell lysis].
    Roveta G; Pagani G
    Boll Soc Ital Biol Sper; 1973 Apr; 49(7):357-61. PubMed ID: 4361896
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biological characteristics of tumor cells and their possibilities for microbiological diagnosis].
    Schneeweiss U; Fabricius EM
    Zentralbl Chir; 1967; 92(26a Pt 2):1636-44. PubMed ID: 4297660
    [No Abstract]   [Full Text] [Related]  

  • 3. Natural antibodies in normal human sera againist the Ehrlich mouse ascites tumour identified with the aid of complement components, utilizing classical reagents.
    Oravec C; Cambelová J
    Neoplasma; 1971; 18(2):141-59. PubMed ID: 5577313
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of macrophages in the cytotoxic killing of tumour cells in vitro. I. Primary immunization of lymphocytes in vitro for target cell killing and the mechanism of lymphocyte-macrophage cooperation.
    Zembala M; Ptak W; Hanczakowska M
    Immunology; 1973 Oct; 25(4):631-44. PubMed ID: 4356674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on inhibitory effect of homologous spleen cells on Ehrlich ascites tumor and Yoshida sarcoma.
    Soeda M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Feb; 26(11):1471-82. PubMed ID: 5231926
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the influencing of immunologic reactions by malignant processes].
    Scheurlen PG; Pappas A
    Verh Dtsch Ges Inn Med; 1971; 77():749-52. PubMed ID: 5156058
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanism of action and cytotoxic, biochemical and histochemical effects of antibodies and complement on neoplastic cells and experimental malignant neoplasms].
    Valguarnera G
    Ann Sclavo; 1974; 16(4):367-85. PubMed ID: 4441141
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anticomplement activity of the serum, ascitic fluid and tumor fluid of animals with transplantable experimental neoplasms. Cytotoxic activity of the antibodies].
    Valguarnera G
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):1013-6. PubMed ID: 4463978
    [No Abstract]   [Full Text] [Related]  

  • 9. [Target cell destruction by sensitized lymphocytes (author's transl)].
    Hashimoto Y; Kitagawa H
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):907-15. PubMed ID: 4216047
    [No Abstract]   [Full Text] [Related]  

  • 10. Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins.
    Mazumder A; Grimm EA; Zhang HZ; Rosenberg SA
    Cancer Res; 1982 Mar; 42(3):913-8. PubMed ID: 7059990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-lapse changes in the concomitant immunity of lymphoid cells from different regions of Ehrlich tumor-bearing mice and alterations in blastformation rate by PHA-stimulation.
    Orita K; Tomoyasu S; Kaneda S; Miwa H; Konaga E
    Acta Med Okayama (1952); 1972 Aug; 26(3):81-8. PubMed ID: 4268711
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunoepidemiological and in vitro studies of possible relationships between Australia antigen and hepatocellular carcinoma.
    Smith JA; Francis TI
    Cancer Res; 1972 Aug; 32(8):1713-20. PubMed ID: 4339749
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reticulo-endothelial reactions in implanted tumors, especially the occurrence of Langhans' giant cells].
    Weissberg M
    Osterr Z Erforsch Bekampf Krebskr; 1971; 26(2):92-106. PubMed ID: 5171285
    [No Abstract]   [Full Text] [Related]  

  • 14. ["Immunochemical endgrouping" with Helix agglutinins of ascites tumor cells. Comparison with the blood cells of animals].
    Prokop O; Graffi A; Schnitzler S
    Acta Biol Med Ger; 1968; 20(3):Suppl:K9-K15. PubMed ID: 4302202
    [No Abstract]   [Full Text] [Related]  

  • 15. [Transplantation of ascites tumor cells pretreated with ribonuclease and phytohemagglutinin].
    Roveta G; Gota F
    Boll Soc Ital Biol Sper; 1968 Oct; 44(20):1678-9. PubMed ID: 5720247
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cold-antibodies in rat serum against Yoshida-hepatom ascites cells].
    Bayer R; von Boehmer H
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 77(1):40-4. PubMed ID: 4336706
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular and humoral immune interactions during neoplastic development.
    Baldwin RW; Bowen JG; Embleton MJ; Price MR; Robins RA
    Johns Hopkins Med J Suppl; 1974; 3():393-407. PubMed ID: 4371716
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experiments on rats for finding out the immune response to a Yoshida hepatoma ascites transplant].
    von Boehmer H; Bayer R
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 77(1):45-56. PubMed ID: 4112266
    [No Abstract]   [Full Text] [Related]  

  • 19. [Attempts of active immunization of rats and mice against "nonspecific" inoculation tumors].
    Weissberg M
    Krebsarzt; 1969; 24(2):66-73. PubMed ID: 5802197
    [No Abstract]   [Full Text] [Related]  

  • 20. Action mechanism in vitro of sensitized regional lymph node cells on target cell. II. Difference in the biological effect of regional lymph node cells of Ehrlich cancer transplanted mouse and that of normal lymph node cells induced by PHA, on Ehrlich cancer cell line (JTC-11 cell).
    Konaga E
    Acta Med Okayama (1952); 1972 Aug; 26(3):99-117. PubMed ID: 4268713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.